1.
Impact of Actinic Keratosis on patient-reported AK symptoms, emotions and functioning measured using Skindex-16, among patients with Actinic Keratosis administered tirbanibulin in real-world community practices across the U.S. (PROAK Study). J of Skin [Internet]. 2023 May 20 [cited 2026 Apr. 19];7(3):s212. Available from: https://skin.dermsquared.com/skin/article/view/2149